Sunshine Biopharma, Inc

Synaptogenix, Inc is a pioneering company based in New York, NY, dedicated to discovering restorative and innovative therapeutics for patients suffering from neurodegenerative diseases and developmental disorders. With a mission to achieve clinically meaningful restoration of cognitive function and regeneration of cerebral connections, Synaptogenix has successfully completed two Phase II pilot study trials and established partnerships with prestigious institutions such as the National Cancer Institute, National Institute of Health, and National Institute of Aging. Led by a management team with over 30 years of experience, the company has secured significant funding and is actively working on indications including Alzheimer's disease, Fragile X Syndrome, Autism, Multiple Sclerosis, Parkinson's Disease, Traumatic Brain Injury, and Stroke. Synapses, the tiny connectors in the brain that allow neurons to communicate, play a crucial role in cognitive functioning. Synaptic loss or dysfunction can lead to impaired cognition and neurodegenerative diseases like Alzheimer's. Synaptogenix's research focuses on the promotion of neuronal health and synaptic regeneration, particularly through the use of Bryostatin, a protein kinase C activator. Their groundbreaking work has shown promising results in restoring hippocampal synapses, improving spatial learning and memory, and reducing amyloid levels associated with Alzheimer's disease. Through their dedication to scientific advancement and collaboration with leading institutions, Synaptogenix aims to rebuild connections and restore lives for individuals affected by these debilitating conditions.Generated from the website

Founded in 1999, AngioGenex is a publicly held biopharmaceutical company that is engaged in the development of applications based on research into Id genes and proteins. It specializes in the discovery of Id-based products for the treatment and diagnosis of cancer and therapeutic care applications. The company additionally develops drugs for diabetes, retinopathy and endometriosis. It provides diagnostic products for oncological conditions and breast, melanoma and cervical cancers. The company specializes in a variety of procedures, such as coronary artery bypass grafting, balloon angioplasty and stent placement. AngioGenex has a partnership with BioCheck for the development and research of diagnostic and treatment products.

Immuno Rx Inc, based in New York, is dedicated to providing innovative treatments for patients and families facing high unmet medical needs. The company's mission is to ensure that individuals have access to effective therapies that can improve their quality of life and overall well-being. Generated from their website's infomation